Hydrogen sulfide (H(2)S), formed by multiple
enzymes, including
cystathionine-γ-
lyase (CSE), targets Ca(v)3.2 T-type Ca(2+) channels (T channels) and transient receptor potential ankyrin-1 (TRPA1), facilitating
somatic pain.
Pancreatitis-related
pain also appears to involve activation of T channels by H(2)S formed by the upregulated CSE. Therefore, this study investigates the roles of the Ca(v)3.2
isoform and/or TRPA1 in pancreatic nociception in the absence and presence of
pancreatitis. In anesthetized mice, AP18, a TRPA1 inhibitor, abolished the Fos expression in the spinal dorsal horn caused by injection of a TRPA1 agonist into the pancreatic duct. As did
mibefradil, a T-channel inhibitor, in our previous report, AP18 prevented the Fos expression following ductal
NaHS, an H(2)S donor. In the mice with
cerulein-induced
acute pancreatitis, the referred
hyperalgesia was suppressed by
NNC 55-0396 (NNC), a selective T-channel inhibitor;
zinc chloride; or
ascorbic acid, known to inhibit Ca(v)3.2 selectively among three T-channel
isoforms; and knockdown of Ca(v)3.2. In contrast, AP18 and knockdown of TRPA1 had no significant effect on the
cerulein-induced referred
hyperalgesia, although they significantly potentiated the antihyperalgesic effect of NNC at a subeffective dose. TRPA1 but not Ca(v)3.2 in the dorsal root ganglia was downregulated at a
protein level in mice with
cerulein-induced
pancreatitis. The data indicate that TRPA1 and Ca(v)3.2 mediate the exogenous H(2)S-induced pancreatic nociception in naïve mice and suggest that, in the mice with
pancreatitis, Ca(v)3.2 targeted by H(2)S primarily participates in the pancreatic
pain, whereas TRPA1 is downregulated and plays a secondary role in pancreatic nociceptive signaling.